GE Healthcare Medical Diagnostics Re-launches Optison" Contrast Agent - QualityPoint Technologies

Links shared publicly online about this topic.

965
total visits

GE Healthcare Medical Diagnostics Re-launches Optison" Contrast Agent - QualityPoint Technologies

GE Healthcare Medical Diagnostics announced the market reintroduction of Optison" (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not

View full resource at qualitypointtech.net

Tags: Imaging Tests, Ultrasound, Healthcare, Exercise and Fitness, Stress Management

Most Recently Shared on August 7, 2010 at 11:51 am By:

MedicalFeed

GE Healthcare Medical Diagnostics Re-launches Optisonâ„¢ Contrast Agent: GE Healthcare Medical Diagnostics announc... http://bit.ly/aiXcaP

2 years ago...

Retweet

Favorite

GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent

medicalnewstoday.com — “GE Healthcare Medical Diagnostics announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent” View full resource at medicalnewstoday.com